- Home
- GXAI vs PTHL Comparison
GXAI vs PTHL Comparison
Compare GXAI & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GXAI
- PTHL
- Stock Information
- Founded
- GXAI 2021
- PTHL 1998
- Country
- GXAI United States
- PTHL China
- Employees
- GXAI N/A
- PTHL N/A
- Industry
- GXAI
- PTHL
- Sector
- GXAI
- PTHL
- Exchange
- GXAI Nasdaq
- PTHL Nasdaq
- Market Cap
- GXAI 12.0M
- PTHL 13.5M
- IPO Year
- GXAI 2023
- PTHL 2024
- Fundamental
- Price
- GXAI $1.84
- PTHL $0.72
- Analyst Decision
- GXAI
- PTHL
- Analyst Count
- GXAI 0
- PTHL 0
- Target Price
- GXAI N/A
- PTHL N/A
- AVG Volume (30 Days)
- GXAI 353.1K
- PTHL 164.7K
- Earning Date
- GXAI 11-13-2025
- PTHL 01-01-0001
- Dividend Yield
- GXAI N/A
- PTHL N/A
- EPS Growth
- GXAI N/A
- PTHL N/A
- EPS
- GXAI N/A
- PTHL N/A
- Revenue
- GXAI $198,711.00
- PTHL $448,196.00
- Revenue This Year
- GXAI N/A
- PTHL N/A
- Revenue Next Year
- GXAI N/A
- PTHL N/A
- P/E Ratio
- GXAI N/A
- PTHL N/A
- Revenue Growth
- GXAI 72158.55
- PTHL N/A
- 52 Week Low
- GXAI $1.00
- PTHL $0.51
- 52 Week High
- GXAI $7.50
- PTHL $32.00
- Technical
- Relative Strength Index (RSI)
- GXAI 55.95
- PTHL 30.39
- Support Level
- GXAI $1.55
- PTHL $0.74
- Resistance Level
- GXAI $2.00
- PTHL $0.85
- Average True Range (ATR)
- GXAI 0.15
- PTHL 0.06
- MACD
- GXAI 0.00
- PTHL 0.19
- Stochastic Oscillator
- GXAI 64.42
- PTHL 12.00
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.